Cargando…
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
Human serum paraoxonase contributes to the anti-atherogenic effect of high-density lipoprotein cholesterol (HDL-C) and has been shown to protect both low-density lipoprotein cholesterol (LDL-C) and HDL-C against lipid peroxidation. We investigated the effects of rosiglitazone on paraoxonase activity...
Autores principales: | Atamer, Y., Atamer, A., Can, A.S., Hekimoğlu, A., Ilhan, N., Yenice, N., Koçyiğit, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Cienífica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854442/ https://www.ncbi.nlm.nih.gov/pubmed/23802228 http://dx.doi.org/10.1590/1414-431X20132818 |
Ejemplares similares
-
Response to: Serum Paraoxonase and Malondialdehyde Levels in Asymptomatic Cholelithiasis
por: Atamer, Aytaç, et al.
Publicado: (2016) -
Evaluation of Paraoxonase, Malondialdehyde, and Lipoprotein Levels in Patients with Asymptomatic Cholelithiasis
por: Atamer, Aytac, et al.
Publicado: (2014) -
The relationship between serum leptin, insulin-like growth factor-1, and insulin-like growth factor binding protein-3 levels and clinical parameters in primary fibromyalgia patients
por: Atamer, Yıldız, et al.
Publicado: (2023) -
Evaluation of second-trimester maternal serum betatrophin levels and lipid and carbohydrate metabolism parameters in patients with gestational diabetes mellitus
por: Gülcü Bulmuş, Funda, et al.
Publicado: (2020) -
Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
por: Kota, Sunil K., et al.
Publicado: (2013)